Company / Total Assets
Decoy Therapeutics Inc. Total Assets History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$14.7M
FY2022
5-year range
$10.4M / $40.8M
FY2018-FY2022
Trend
-64.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $25M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2022 with a 5-year CAGR of -16.0%.
Declined from $25M to $15M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +1.8%
- 5-Year CAGR
- -16.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -16.0%, indicating a declining trend.
- In FY2022, total assets decreased 64.1% year-over-year.
- Peak total assets was recorded in FY2016.
- Lowest total assets in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $14.7M | -64.1% |
| FY2021 | $40.8M | +63.8% |
| FY2020 | $24.9M | +79.4% |
| FY2019 | $13.9M | +33.7% |
| FY2018 | $10.4M | -70.3% |
| FY2017 | $35.0M | -44.6% |
| FY2016 | $63.2M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026